143
Views
11
CrossRef citations to date
0
Altmetric
Review

Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview

ORCID Icon & ORCID Icon
Pages 1341-1366 | Published online: 25 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

James Yu, Amit Mahipal & Richard Kim. (2021) Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib. OncoTargets and Therapy 14, pages 5145-5160.
Read now

Articles from other publishers (10)

Usman Saeed, Marie Nordsletten, Tor Å. Myklebust, Trude E. Robsahm, Bjørn Møller, Bjørn Steen Skålhegg, Tom Mala & Sheraz Yaqub. (2023) Cancer risk and survival according to body mass index in hepatobiliary malignancies: a nationwide registry-based cohort study. HPB 25:11, pages 1382-1392.
Crossref
Ahmed S. Doghish, Heba M. Midan, Abdullah M.M. Elbadry, Samar F. Darwish, Nehal I. Rizk, Bassant O. Ziada, Amir S. Elbokhomy, Mahmoud A. Elrebehy, Mohammed S. Elballal, Hussein M. El-Husseiny, Sherif S. Abdel Mageed & Ahmed I. Abulsoud. (2023) The potential role of miRNAs in the pathogenesis of gallbladder cancer – A focus on signaling pathways interplay. Pathology - Research and Practice 248, pages 154682.
Crossref
Maurizio Capuozzo, Mariachiara Santorsola, Loris Landi, Vincenza Granata, Francesco Perri, Venere Celotto, Oreste Gualillo, Guglielmo Nasti & Alessandro Ottaiano. (2022) Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology. International Journal of Molecular Sciences 23:23, pages 15124.
Crossref
Chi-Yuan Cheng, Chiao-Ping Chen & Chiao-En Wu. (2022) Precision Medicine in Cholangiocarcinoma: Past, Present, and Future. Life 12:6, pages 829.
Crossref
Daneng Li, Ya-Han Zhang, Christiana J. Crook & Renuka V. Iyer. (2022) Updates in Biliary Tract Cancers. Cancers 14:11, pages 2746.
Crossref
Chao Yin, Monika Kulasekaran, Tina Roy, Brennan Decker, Sonja Alexander, Mathew Margolis, Reena C. Jha, Gary M. Kupfer & Aiwu R. He. (2022) Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?. Cancers 14:10, pages 2561.
Crossref
Sridhar Mishra, Swati Kumari, Pallavi Srivastava, Anshuman Pandey, Saumya Shukla & Nuzhat Husain. (2022) Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved. Pathology - Research and Practice 232, pages 153806.
Crossref
Massimiliano Cadamuro, Rocio I.R. Macias, Alastair J. Strain, Mario Strazzabosco, Paolo Simioni, Jose J.G. Marin & Luca Fabris. (2021) Unmet needs in basic and translational research in Cholangiocarcinoma. Liver Cancer International 3:1, pages 5-16.
Crossref
Xiao Xiao, Jun Zhou, Meng Fang, Jun Ji, Chenjun Huang, Fei Du, Wenchao Ai, Ying Wang, Zhiyuang Gao, Zhiquan Qiu & Chunfang Gao. (2021) Quantitative detections of TP53 gene mutations improve the diagnosis and prognostic prediction of biliary tract cancers using droplet digital PCR. Journal of Clinical Laboratory Analysis 36:1.
Crossref
Brinda Balasubramanian, Simran Venkatraman, Tavan Janvilisri, Tuangporn Suthiphongchai, Siriporn Jitkaew, Jittiyawadee Sripa & Rutaiwan Tohtong. (2021) RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach. Pharmaceuticals 14:9, pages 898.
Crossref